Changes in visual acuity in patients with wet age-related macular degeneration treated with intravitreal ranibizumab in daily clinical practice: the LUMIERE study.

@article{Cohen2013ChangesIV,
  title={Changes in visual acuity in patients with wet age-related macular degeneration treated with intravitreal ranibizumab in daily clinical practice: the LUMIERE study.},
  author={Salomon Yves Cohen and Gerard Mimoun and Hassiba Oubraham and Alain Zourdani and Christian Malbrel and St{\'e}phane Qu{\'e}r{\'e} and V. M. Schneider},
  journal={Retina},
  year={2013},
  volume={33 3},
  pages={474-81}
}
PURPOSE To survey compliance with recommended intravitreal ranibizumab treatment protocols in daily clinical practice in France, with reference to outcomes. METHODS A retrospective, descriptive, observational study in patients with subfoveal wet age-related macular degeneration treated with ranibizumab. All historical data for the study period, including demographic, treatment, and disease details and visual acuity measurements (baseline, Month 3, and Month 12), were recorded retrospectively… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 44 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 25 references

Eter N, on behalf of the SUSTAIN Study Group. Safety and efficacy of ranibizumab treatment in patients with neovascular age-related macular degeneration: 12-month results of the SUSTAIN study

  • FG Holz, C Meyer
  • Presented at: Association for Research in Vision…
  • 2009

Similar Papers

Loading similar papers…